Afshari C A, Barrett J C
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Mol Carcinog. 1993;7(4):249-56. doi: 10.1002/mc.2940070407.
Immortal, nontumorigenic cell lines of Syrian hamster embryo (SHE) cells with different tumor-suppressing activity were isolated. Subclones from the parental cells were isolated that either had retained (supB+) or lost (supB-) the ability to suppress tumorigenicity after hybridization with tumor cells. The growth properties of these cells were studied to determine how this tumor-suppressor gene function influences cell growth. When the cells were grown on plastic, their growth properties were similar, and neither cell type grew in soft agar containing 10% serum, which supported the growth of tumorigenic cells. However, in agar supplemented with growth factors and 10% serum, supB- cells formed colonies whereas supB+ cells did not. Efficient growth (colony-forming efficiencies greater than 20%) of supB- cells was obtained in agar supplemented with serum and a combination of epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and insulin (EPI) or with serum and basic fibroblast growth factor (bFGF). The effect of EPI and bFGF together was additive. supB+ cells failed to grow under any of these conditions, suggesting that the suppressor gene function blocked the growth response of the cells to multiple growth factors when the cells were suspended in agar. In SupB- cells, transforming growth factor-beta 1 and retinoic acid inhibited anchorage-independent growth response to EPI but not the growth response to bFGF. These observations are consistent with the hypothesis that bFGF stimulates the growth of supB- cells by a signal transduction pathway that differs from the pathway stimulated by EGF or PDGF. Thus, this suppressor gene function may regulate anchorage-independent growth at some common point in signal transduction for multiple mitogens.
分离出具有不同肿瘤抑制活性的叙利亚仓鼠胚胎(SHE)细胞的永生、非致瘤细胞系。从亲代细胞中分离出亚克隆,这些亚克隆在与肿瘤细胞杂交后,要么保留了(supB+),要么丧失了(supB-)抑制致瘤性的能力。研究了这些细胞的生长特性,以确定这种肿瘤抑制基因功能如何影响细胞生长。当细胞在塑料上生长时,它们的生长特性相似,两种细胞类型在含有10%血清的软琼脂中均不生长,而这种软琼脂能支持致瘤细胞的生长。然而,在添加了生长因子和10%血清的琼脂中,supB-细胞形成集落,而supB+细胞则不形成。在添加血清以及表皮生长因子(EGF)、血小板衍生生长因子(PDGF)和胰岛素(EPI)的组合或血清和碱性成纤维细胞生长因子(bFGF)的琼脂中,supB-细胞获得了高效生长(集落形成效率大于20%)。EPI和bFGF共同作用的效果是相加的。supB+细胞在这些条件下均未能生长,这表明当细胞悬浮在琼脂中时,抑制基因功能阻断了细胞对多种生长因子的生长反应。在SupB-细胞中,转化生长因子-β1和视黄酸抑制了对EPI的不依赖贴壁生长反应,但不抑制对bFGF的生长反应。这些观察结果与以下假设一致,即bFGF通过一条不同于EGF或PDGF刺激的信号转导途径刺激supB-细胞的生长。因此,这种抑制基因功能可能在多种有丝分裂原信号转导的某个共同点上调节不依赖贴壁的生长。